Concepedia

David B. Lovejoy

DB

17

Publications

2.5K

Citations

16

H-Index

2002

Active since

Affiliations

The University of Sydney(Current)

The University of Queensland

Robert Bosch (Australia)

Children's Cancer Institute Australia

Howard University

David B. Lovejoy is an author at The University of Sydney specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

2002–2013

17

Publications

17

Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment

Jun Yuan, David B. Lovejoy, Des R. Richardson · Blood · 2004 · 384 citations · Full text

Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity

Des R. Richardson, Philip C. Sharpe, David B. Lovejoy et al. · Journal of Medicinal Chemistry · 2006 · 381 citations

, , +17

Design, Synthesis, and Characterization of Novel Iron Chelators:  Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents

Danuta S. Kalinowski, Yu Yu, Philip C. Sharpe et al. · Journal of Medicinal Chemistry · 2007 · 220 citations

Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites

Asikiya Walcourt, Mark Loyevsky, David B. Lovejoy et al. · The International Journal of Biochemistry & Cell Biology · 2003 · 211 citations

, , +7

2-Acetylpyridine Thiosemicarbazones are Potent Iron Chelators and Antiproliferative Agents: Redox Activity, Iron Complexation and Characterization of their Antitumor Activity

Des R. Richardson, Danuta S. Kalinowski, Věra Richardson et al. · Journal of Medicinal Chemistry · 2009 · 199 citations

Rows per page

1–5 of 17